BVF Inc/il, 10% Owner at Cullinan Oncology, Inc. (CGEM), bought 2,219,800 shares at $9.14 ($20.1M) on 2022-05-13, disclosed to the SEC on 2022-05-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.06 | 457,001 | $4.1M | 20.6% |
| 2 | $9.06 | 457,001 | $4.1M | 20.6% |
| 3 | $9.06 | 542,999 | $4.9M | 24.4% |
| 4 | $9.06 | 542,999 | $4.9M | 24.4% |
| 5 | $9.14 | 17,744 | $162K | 0.8% |
| 6 | $9.14 | 17,744 |
| $162K |
| 0.8% |
| 7 | $9.14 | 38,558 | $352K | 1.8% |
| 8 | $9.14 | 38,558 | $352K | 1.8% |
| 9 | $9.14 | 53,598 | $490K | 2.4% |
| 10 | $9.14 | 53,598 | $490K | 2.4% |
| Total | $9.07 avg | 2,219,800 | $20.1M | 100% |
| Filing → |
| PNT | SELL | 2023-12-20 | $427.3M | — | Filing → |
| KYMR | BUY | 2022-05-09 | $8.3M | — | Filing → |
| KYMR | BUY | 2022-01-31 | $10.2M | — | Filing → |